Recommended Alerts

Sign Up For Alerts

FDA and NIH Release Guidance on Ongoing Clinical Trials Affected by COVID-19

The COVID-19 pandemic has had a major impact on the conduct of clinical trials worldwide. Restrictions on travel, dislocation of clinical trial subjects, and the need of many health care facilities to handle an influx of patients with COVID-19 have combined to disrupt the conduct of clinical trials.

Read More

Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act

Practices: Health Care

Printer-Friendly Version

Cookie Settings